GlassScriptPhysician profile
Ali R Khan
NPI 1760714380
$4,286.83
in general payments reported to CMS, 2019-2025
37 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $550 · 2021: $1,662 · 2022: $1,224 · 2023: $471 · 2024: $27.16 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $850.97 | 2020-2023 | |
| Novo Nordisk INC | $401.95 | 2020-2023 | Rybelsus, Ozempic |
| Pfizer INC. | $371.93 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $344.53 | 2020-2024 | Belsomra, Steglatro, Dificid |
| Biohaven Pharmaceuticals, INC. | $246.41 | 2021 | |
| Eisai INC. | $155.97 | 2020-2021 | |
| Glaxosmithkline, LLC. | $148.28 | 2020-2023 | Shingrix, Bexsero, Arexvy |
| Allergan, INC. | $141.15 | 2019-2020 | |
| Clarus Therapeutics INC. | $134.62 | 2021 | |
| Heartflow, INC. | $131.18 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $120.79 | 2022 | |
| Amarin Pharma, INC. | $117.69 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.50 | 2020-2023 | Xifaxan |
| Amgen INC. | $116.03 | 2020-2023 | Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.20 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $93.93 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $93.69 | 2020-2023 | Farxiga |
| Esperion Therapeutics, INC. | $83.72 | 2021 | |
| Janssen Pharmaceuticals, INC | $58.94 | 2019 | |
| Veran Medical Technologies, INC. | $57.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.92 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $48.57 | 2023 | Rexulti |
| Currax Pharmaceuticals LLC | $40.74 | 2020-2022 | |
| Lilly USA, LLC | $27.84 | 2021-2023 | Jardiance |
| Nevro Corp. | $27.53 | 2022-2023 | Senza |
| Astellas Pharma US INC | $23.95 | 2023 | Cresemba |
| Axsome Therapeutics, INC. | $22.15 | 2023 | Sunosi |
| Althera Pharmaceuticals LLC | $19.94 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $19.79 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.10 | 2022 | |
| Jazz Pharmaceuticals INC. | $16.61 | 2021 | |
| Horizon Therapeutics Plc | $15.51 | 2021 | |
| Medtronic, INC. | $14.30 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.12 | 2019 | |
| Aytu Biopharma, INC. | $13.88 | 2020 | |
| Tactile Systems Technology INC | $12.75 | 2022 | |
| Gilead Sciences, INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.